Longitudinal dynamics of hemostatic biomarkers in patients with cancer receiving immune checkpoint inhibitors vs chemotherapy: results from the Vienna CAT-BLED study
Hemostatic biomarker levels were largely comparable between the 2 treatment modalities and showed increasing trends over time.
Authors
- Thorsten Fuereder (ORCID: https://orcid.org/0000-0001-5356-6452)
- Ingrid Pabinger (ORCID: https://orcid.org/0000-0002-7677-9896)
- Cornelia Englisch (ORCID: https://orcid.org/0000-0001-9007-7738)
- Cihan Ay (ORCID: https://orcid.org/0000-0003-2607-9717)
- J. Thaler (ORCID: https://orcid.org/0000-0002-9613-8658)
- Matthias Preusser (ORCID: https://orcid.org/0000-0003-3541-2315)
- J.M. Berger (ORCID: https://orcid.org/0000-0002-1695-8577)
- Hubert Hayden
- Florian Moik (ORCID: https://orcid.org/0000-0001-7738-4119)
- Nikola Vladić (ORCID: https://orcid.org/0009-0002-3806-2250)
Institutions
- Medical University of Graz (AT)
- Medical University of Vienna (AT)
Publication Details
- Journal
- Research and Practice in Thrombosis and Haemostasis
- Published
- 2025-05-01
- DOI
- https://doi.org/10.1016/j.rpth.2025.102933
- Citations
- 1
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 1.05